Pathomorphological Verification of Diffuse Non-Hodgkin Lymphoma with Predominant Involvement of the Spleen and Abdominal Lymph Nodes
https://doi.org/10.22448/AMJ.2026.1.33-38
EDN: RSLUFU
Abstract
The article presents a clinical observation of diffuse non-Hodgkin lymphoma with predominant involvement of the spleen and abdominal lymph nodes in a 59-year-old female patient, which during life manifested "under the guise" of fever of unknown origin, severe intoxication syndrome, and profound anemia. Instrumental studies revealed significant splenomegaly and a large focal lesion of the spleen in the absence of convincing evidence confirming gastrointestinal mucosal involvement. According to the results of trephine biopsy, the bone marrow material contained no reliable signs of specific lymphoid involvement. Final verification of the lymphoma was obtained posthumously based on an autopsy study with morphological confirmation of diffuse infiltration of the spleen by atypical large lymphoid cells with high mitotic activity and destruction of the organ architecture. This case demonstrates the limitations of antemortem diagnosis of lymphoproliferative diseases with predominantly visceral involvement and highlights the role of pathological autopsy as a tool for quality control of diagnosis.
Keywords
About the Authors
M. A. LizunovaRussian Federation
Milena A. Lizunova
Belogorsk
T. S. Churikova
Russian Federation
Tatiana S. Churikova
Blagoveshchensk
I. Yu. Makarov
Russian Federation
Igor Yu. Makarov
Blagoveshchensk
References
1. Alaggio R., Amador C., Anagnostopoulos I., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia. 2022; 36 (7): 1720–1748. DOI: https://doi.org/10.1038/s41375-022-01620-2
2. Sehn L.H., Salles G. Diffuse Large B-Cell Lymphoma. The New England Journal of Medicine. 2021; 384 (9): 842–858. DOI: https://doi.org/10.1056/NEJMra2027612
3. Petersdorf R.G., Beeson P.B. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961; 40 (1): 1–30. DOI: https://doi.org/10.1097/00005792-196102000-00001
4. Unger M., Karanikas G., Kerschbaumer A., et al. Fever of unknown origin (FUO) revised. Wiener klinische Wochenschrift. 2016; 128 (21–22): 796–801. DOI: https://doi.org/10.1007/s00508-016-1083-9
5. International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. The New England Journal of Medicine. 1993; 329 (14): 987–994. DOI: https://doi.org/10.1056/NEJM199309303291402
6. Matsumoto K., Yamamoto W., Takahashi H., et al. Anemia Associated with Worse Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Therapy. Turkish Journal of Haematology. 2018; 35 (3): 181–187. DOI: https://doi.org/10.4274/tjh.2017.0437
7. Yoshida N., Takizawa J., Watanabe T., et al. Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Cancer Science. 2014; 105 (12): 1569–1575. DOI: https://doi.org/10.1111/cas.12544
8. Alyamany R., Riad E.F., Ahmed А., et al. A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with diffuse large B-cell lymphoma. Frontiers in Oncology. 2024; 14: 1301979. DOI: https://doi.org/10.3389/fonc.2024.1301979
9. Disanto M.G., Ambrosio M.R., Rocca B.J., et al. Optimal Minimal Panels of Immunohistochemistry for Diagnosis of B-Cell Lymphoma for Application in Countries With Limited Resources and for Triaging Cases Before Referral to Specialist Centers. American Journal of Clinical Pathology. 2016; 145 (5): 687–695. DOI: https://doi.org/10.1093/ajcp/aqw060
10. Cho J. Basic immunohistochemistry for lymphoma diagnosis. Blood Research. 2022; 57 (Suppl 1): 55– 61. DOI: https://doi.org/10.5045/br.2022.2022037
11. Podduturi V., Thota S., Pinnix C.C., et al. A Case Series of Clinically Undiagnosed Hematopoietic Neoplasms Discovered at Autopsy. American Journal of Clinical Pathology. 2015; 143 (6): 854–861. DOI: https://doi.org/10.1309/AJCPAY9ZIS1XEPRO
12. Shojania K.G., Burton E.C., McDonald K.M., Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. Journal of the American Medical Association. 2003; 289 (21): 2849–2856. DOI: https://doi.org/10.1001/jama.289.21.2849
Review
For citations:
Lizunova M.A., Churikova T.S., Makarov I.Yu. Pathomorphological Verification of Diffuse Non-Hodgkin Lymphoma with Predominant Involvement of the Spleen and Abdominal Lymph Nodes. Amur Medical Journal. 2026;14(1):33-38. (In Russ.) https://doi.org/10.22448/AMJ.2026.1.33-38. EDN: RSLUFU
JATS XML











